Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$213,514
-$68,431 QoQ
Shares Held
1,690
-16.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,888
of 2,266 holders
Holding Since
Jun 2021
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WADDELL & ASSOCIATES, LLC holds $17,002,805 across 9 Drug Manufacturers - General names. GILD ranks #9 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,432 | $6,515,304 | |
| 2 | JNJ |
Johnson & Johnson
|
10,973 | $2,786,812 | |
| 3 | MRK |
Merck & Co., Inc.
|
21,357 | $2,744,374 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
33,126 | $1,908,720 | |
| 5 | PFE |
Pfizer Inc
|
40,111 | $965,872 | |
| 6 | ABBV |
AbbVie Inc.
|
3,688 | $928,048 | |
| 7 | BIIB |
Biogen Inc.
|
2,967 | $641,050 | |
| 8 | AMGN |
Amgen Inc
|
826 | $299,111 |
All Filings in GILD
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $213,514 | 1,690 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $281,945 | 2,023 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $209,394 | 1,706 | Shares | Sole | 2026-02-11 | |
| 2022-09-30 | $243,798 | 3,952 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $291,310 | 4,713 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $235,243 | 3,957 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $287,317 | 3,957 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $270,459 | 3,872 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $266,625 | 3,872 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||